BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang LP, Ren H, Du YX, Wang CF. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastroenterol 2020; 26(46): 7382-7404 [PMID: 33362391 DOI: 10.3748/wjg.v26.i46.7382]
URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7382.htm
Number Citing Articles
1
Enhao Wang, Yang Li, Ruijie Ming, Jiahui Wei, Peiyu Du, Peng Zhou, Shimin Zong, Hongjun Xiao. The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell CarcinomaFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.718974
2
Aneta Szmiel, Alicja Majos, Wojciech Ciesielski, Anna Kumor, Janusz Strzelczyk, Krzysztof Szwedziak, Piotr Hogendorf, Adam Durczyński. Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour—Pilot StudyJournal of Clinical Medicine 2022; 11(6): 1573 doi: 10.3390/jcm11061573
3
Nansong Xu, Changchun Lai, Qing-Mei He, Yubo Cai, Hui Yu, Wenhao Zhong, Shulin Chen, Fang-Cai Wu, Hao Chen. Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilitiesLife Sciences 2023; 332: 122078 doi: 10.1016/j.lfs.2023.122078
4
V. La Vaccara, R. Cammarata, A. Coppola, T. Farolfi, C. Cascone, S. Angeletti, G. Maltese, R. Coppola, D. Caputo. Data of postoperative complications related to fibrinogen-to-albumin ratio in pancreatic resectionsData in Brief 2022; 42: 108064 doi: 10.1016/j.dib.2022.108064
5
Rong-yun Mai, Tao Bai, Xiao-ling Luo, Guo-bin Wu. Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomyBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02328-4
6
Guojie Zhao, Changjing Wang, Jian Jiao, Wei Zhang, Hongwei Yang. The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1045477
7
Yuanlong Gu, Qianjin Hua, Zhipeng Li, Xingli Zhang, Changjie Lou, Yangfen Zhang, Wei Wang, Peiyuan Cai, Juan Zhao. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancerBMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10653-4
8
Baibei Li, Huachu Deng, Biao Lei, Leijie Chen, Xinyuan Zhang, Dingran Sha. The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.985377
9
Haoli Gong, Ye Tao, Sheng Xiao, Xin Li, Ke Fang, Jie Wen, Ming Zeng, Yiheng Liu, Yang Chen. Identification of an EMT‐related gene‐based prognostic signature in osteosarcomaCancer Medicine 2023; 12(11): 12912 doi: 10.1002/cam4.5942
10
Jiehui Cai, Zeqi Ji, Jinyao Wu, Lingzhi Chen, Daitian Zheng, Yaokun Chen, Xinkang Zhang, Wanchun Xie, Jieying Huang, Manqi Chen, Ru Lin, Weixun Lin, Yexi Chen, Zhiyang Li. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.949314
11
Biagio Barone, Luigi Napolitano, Pasquale Reccia, Luigi De Luca, Simone Morra, Carmine Turco, Alberto Melchionna, Vincenzo Francesco Caputo, Luigi Cirillo, Giovanni Maria Fusco, Francesco Mastrangelo, Francesco Paolo Calace, Ugo Amicuzi, Vincenzo Morgera, Lorenzo Romano, Massimiliano Trivellato, Gennaro Mattiello, Enrico Sicignano, Francesco Passaro, Gianpiero Ferretti, Gaetano Giampaglia, Federico Capone, Celeste Manfredi, Felice Crocetto. Preoperative Fibrinogen-to-Albumin Ratio as Potential Predictor of Bladder Cancer: A Monocentric Retrospective StudyMedicina 2022; 58(10): 1490 doi: 10.3390/medicina58101490
12
Jingsheng Hua, Tianling Ding, Yanping Shao. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemiaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1040661